drugset / Trial / NCT02790853
Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders
Phase 0
Active not recruiting
63 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This early phase I trial studies how well multimodal imaging works for surveillance in patients with oral potentially malignant disorders. New types of imaging devices may help doctors decide if a lesion in the mouth is pre-cancerous or cancerous.
Timeline
- Start
- 2016-05-25
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Proflavine Hemisulfate | Diagnostic / imaging agent | — | Topical |